In an extensive analysis titled “Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and Long COVID-19,” a team of researchers has offered fascinating insights into the possible role of cannabinoids in combatting COVID-19. The review, written by Cassidy Scott, Stefan Hall, Juan Zhou, and Christian Lehmann, examines data from prior studies to determine how constituents of the cannabis plant might play a crucial part in preventing or mitigating the long-lasting effects of COVID-19. The findings suggest that cannabinoids, especially those in cannabis extracts, could inhibit the virus’s entry into cells, reduce dangerous oxidative stress, and regulate the excessive immune response often seen in severe cases.
Potential of Cannabinoids in Preventing Viral Entry
According to the study, cannabinoids exhibit the potential to obstruct viral entry into human cells, alleviate oxidative stress, and mitigate the cytokine storm associated with COVID-19. The research implies that particular cannabis extracts can lower ACE2 protein levels in vital tissues, subsequently impeding the entry of the virus into human cells.
Cannabinoids’ Role in Combating Oxidative Stress
The review also delves into cannabinoids’ involvement in addressing oxidative stress, which significantly contributes to the progression of COVID-19. By transforming free radicals into less active forms, cannabinoids such as CBD may help lessen the harmful effects of oxidative stress observed in acute cases of COVID-19.
Alleviating the Cytokine Storm Through Cannabinoids
Furthermore, the study indicates that cannabinoids might positively impact the cytokine storm—a severe immune response triggered by COVID-19. Researchers also analyzed how cannabinoids could be employed to treat lingering symptoms from Long-COVID. These symptoms include depression, anxiety disorders, post-traumatic stress injury (PTSI), insomnia, pain management, and decreased appetite.
Different Methods of Cannabis Consumption
The research considers various methods of consumption and the different kinds of cannabis products users typically consume. The authors highlight the potential adverse effects of smoke inhalation on patients with respiratory illnesses, which may counteract any therapeutic benefits offered by cannabinoid treatments.
Call for Further Research in Cannabinoids and COVID-19 Treatment
The researchers emphasize the need for more extensive and targeted research in this area, including clinical trials, to fully comprehend the role and effectiveness of cannabinoids in treating both early and post-acute SARS-CoV-2 infections. As the world continues to grapple with the ongoing pandemic, exploring alternative treatment options has become vital in addressing COVID-19’s short-term and long-lasting effects. As such, further investigation into the potential benefits of cannabinoids could pave the way for developing innovative therapies against the virus and improving overall patient outcomes.
Rita Ferreira
Rita is a seasoned writer with over five years of experience, having worked with globally renowned platforms, including Forbes and Miister CBD. Her deep knowledge of hemp-related businesses and passion for delivering accurate and concise information distinguish her in the industry. Rita's contributions empower individuals and companies to navigate the complexities of the cannabis world, and her work remains a valuable resource for those seeking a deeper understanding of its potential.
